A Wolfpack Research short report published in late January revealed that up to 86% of IonQ’s revenue from 2022 through 2024 derived from Pentagon contracts that Congress has decided not to renew. The report estimates a potential $54.6 million gap in expected revenue for 2026 if these defense contracts are not replaced by equivalent commercial bookings. This revelation triggered a steep sell-off in IonQ shares, as investors grew concerned about the company’s overreliance on a single customer segment and the difficulty of rapidly securing alternative contracts of similar scale.

IonQ forecasts a net loss of $1.5 billion for fiscal year 2025, driven by continued investment in research and development, expansion of manufacturing facilities, and sales and marketing efforts to penetrate new markets. Cash flow statements for the first nine months of 2025 show the company spent $259 million on operations, reducing its cash reserves to $320 million at year-end. Several Wall Street analysts have downgraded their revenue growth projections for 2026, arguing that even with strong demand for quantum services, the pace of new customer wins must accelerate significantly to offset the Pentagon shortfall.

IonQ will report its financial results for the quarter ending December 31, 2025 on February 25, 2026, with a conference call scheduled at 4:30 PM Eastern the same day. Management has hinted that revenue growth in Q4 was driven by increased usage on cloud platforms including Amazon Web Services and strategic partnerships in pharmaceutical R&D. The call will provide updated guidance for 2026 bookings and outline plans to bridge the revenue gap left by the expired defense contracts. Investors will also look for data on capital expenditures for the company’s new quantum production facility in College Park, Maryland.

IonQ remains the largest quantum computing platform by valuation and continues to hold a technological lead with its upcoming IonQ Tempo system, which promises improved scalability and lower error rates. In 2025 the company set a world record with 99.99% two-qubit gate fidelity, a metric critical for complex quantum algorithms. Major customers including AstraZeneca and NVIDIA report up to 20x performance gains in drug discovery simulations and materials modeling. IonQ’s strategy of integrating hardware, control software, and cloud deployment has attracted interest from logistics and cybersecurity firms seeking to pilot quantum-enhanced solutions.